-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Initiates Coverage On CareDx with Buy Rating, Announces Price Target of $65

Benzinga·09/02/2026 15:40:34
语音播报
Canaccord Genuity analyst Kyle Mikson initiates coverage on CareDx (NASDAQ:CDNA) with a Buy rating and announces Price Target of $65.